Fibroid Research

X-ray guided technique a new option for fibroids, enlarged prostate

Embolization isn’t exactly an everyday word, but many Americans learned about it when Melania Trump had such a procedure in May. “This morning, First Lady Melania Trump underwent an embolization procedure to treat a benign kidney condition,” the White House communications director announced on May 14. The statement said the procedure was successful and there…

Read More

TRUST Study to look at the costs of fibroid care

The article below discusses one of several ongoing medical research studies about the benefits of three different types of fibroid treatments. In the TRUST Study, one of the end goals is to determine which of the 3 treatments is the most cost effective for women and their health insurance carriers. Another promising study is the…

Read More

Sonata Technology Platform Featured in Presentations at Upcoming Congress

Gynesonics, a women’s healthcare company focused on the development of advanced incision-free solutions for the treatment of uterine conditions, today announced that its Sonata® System technology platform for transcervical incision-free treatment of uterine fibroids will be featured in three presentations at the 61st Annual German Society of Obstetrics and Gynecology (DGGG) Congress to be held…

Read More

Nationwide project will track uterine fibroid treatment outcomes

A cohort of 10 clinical centers across the U.S. recently announced that they will collaborate on a large-scale study on the effectiveness of various treatments for uterine fibroids. Uterine fibroids are a common type of benign tumor in women. Some are entirely asymptomatic, while others can cause significant pain, bleeding and fertility problems. “Uterine fibroids…

Read More

Michigan joins national, $20M research project to improve fibroid treatment

The University of Michigan will join nine other clinical centers across the country working to compare the effectiveness of different treatment strategies for women with uterine fibroids. The five-year, $20 million project is funded by The Patient-Centered Outcomes Research Institute (PCORI) and the Agency for Healthcare Research and Quality (AHRQ). The effort centers around building…

Read More

BioSpecifics creates successful non-surgical uterine fibroid treatment

BioSpecifics Technology Corp. published a paper on Tuesday detailing the efficacy of its collagenase clostridium histolyicum (CCH) vaccine prototype for the treatment of uterine fibroids, finding a decreased fibroid stiffness. The article, titled “Loss of Stiffness in Collagen-Rich Uterine Fibroids after Digestion with Purified Collagenase Clostridium Histolyticum,” was published in the American Journal of Obstetrics…

Read More